Soleus Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-117,500
| Closed | -$4.22M | – | 90 |
|
|
2024
Q3 | $4.22M | Sell |
117,500
-83,500
| -42% | -$3M | 0.33% | 63 |
|
|
2024
Q2 | $7.09M | Buy |
+201,000
| New | +$7.09M | 0.63% | 50 |
|
|
2022
Q1 | – | Sell |
-338,760
| Closed | -$4.03M | – | 72 |
|
|
2021
Q4 | $4.03M | Buy |
338,760
+160,400
| +90% | +$1.91M | 0.4% | 41 |
|
|
2021
Q3 | $2.9M | Hold |
178,360
| – | – | 0.45% | 55 |
|
|
2021
Q2 | $3.75M | Buy |
178,360
+4,000
| +2% | +$84.2K | 0.58% | 37 |
|
|
2021
Q1 | $2.71M | Buy |
+174,360
| New | +$2.71M | 0.49% | 42 |
|